Bloodwork question about liraglutide. Baseline, two months in, and the numbers moved in a direction I did not expect.
The animal data is stronger than the human data and the human data is not nothing, it is just small.
I would rather have a narrow conclusion and be right than a broad one and be interesting.
Tolerance and underdosing look identical from the inside, which is why the answer is usually a blood test and not more forums.
What the GLP-1 class does pharmacologically does not require the subjective effect to be large to be real.
Interested in the methods more than the conclusion.
Nobody has ever been talked out of a stack by a stranger on the internet.
Read methods.
Loose evidence is not nothing, but a washout either side is the only reason to trust your own take.
Where does the human data stop and the extrapolation begin? That is the whole thread.
If it needs three other compounds to notice, you have not tested the first one. Not on liraglutide but the pattern is familiar.
How long before you can reasonably say something is or is not doing anything?
Nobody has ever been talked out of a stack by a stranger on the internet.
Same here.
Nausea was my main issue with liraglutide too.
Is a baseline blood test really necessary before starting something like this?
Stupid question: how do you know whether what is in the vial matches the label at all?
Baseline first.
How long before you can reasonably say something is or is not doing anything?
Most of what is called evidence here is one person, one vial, one month.
Baseline first. Without a baseline the after picture is decoration. Nausea was my main issue with liraglutide too.